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Abstract

Purpose:  Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating condition characterised by a number of symptoms which typically worsen following minimal exertion. Various strategies to manage the limited energy levels have been proposed. Of these, pacing has been consistently rated as one of the most helpful in surveys conducted by patient groups. This review is a response to the paucity of the information on pacing in the scientific literature. 
Method:  We describe the principle of pacing and how this can be adapted to meet individual abilities and preferences. A critical evaluation of the research was conducted to ascertain the benefits and limitations of this strategy.  
Results: Based on various studies, it is proposed that pacing can help to stabilise the condition and avoid post-exertional malaise. 
Conclusion: Pacing offers practitioners an additional therapeutic option which is acceptable to the majority of patients and can reduce the severity of the exertion-related symptoms of ME/CFS.  

Key words: chronic fatigue syndrome, myalgic encephalomyelitis, pacing, activity, envelope theory, fatigue. 


Introduction

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disabling condition of unknown origin [1]. On measures assessing the impact of disorders on daily life, patients with ME/CFS record higher scores than patients with various types of cancer, rheumatoid arthritis, multiple sclerosis, end-state renal disease, depression and bipolar disorder [2-4]. One of the cardinal features of ME/CFS is the exacerbation of fatigue and other symptoms following minimal exertion [1,5]. Post-exertional malaise (PEM) is a diagnostic criterion in the most commonly used research case definitions and the close association  between symptoms and activity is also recognised in the more recently devised clinical criteria for adults [1,5,6] and children [7]. Studies support the view that the presence of PEM increases diagnostic precision, particularly because of the high prevalence of fatigue in the general population [8], as well as in conditions such as multiple sclerosis [9] and depression [10]. 
As PEM may increase the illness burden for several weeks [8,11], psychologists devised a strategy known as pacing [12,13]. This is defined as an approach where patients are encouraged to be as active as possible within the limits imposed by the illness. In practice, pacing requires the individual to determine a level at which they can function but which does not lead to a marked increase in fatigue and other symptoms for up to five days [8,14]. Minor and transient symptoms which do not make the person feel unwell may be ignored. Typical  cues that patients have exceeded their ‘limits’ include the onset of muscle weakness, muscle stiffness, pain, dizziness, headache and a flu-like malaise [8,15]. Depending on the nature and severity of the symptoms, patients can either stop and rest or change to an activity involving a different muscle group, or both [12].  
Due to the lack of evidence that it is effective in significantly reducing a broad range of symptoms, pacing is not envisaged as a treatment for the illness as a whole. Instead, it is advocated that it be offered as one component of a tailor-made, multi-disciplinary programme which addresses the specific needs and circumstances of the individual with ME/ CFS [13,16-17]. It provides practitioners with an additional therapeutic option and in particular, an alternative to time-contingent strategies aimed at increasing activity levels and improving strength and endurance [18,19]. The latter are based on the assumption that PEM is a transient reaction to deconditioning and that the decision to rest when unwell is a “learned response” which alleviates the symptoms in the short-term, but decreases the individual’s fitness in the long-term [20]. These protocols therefore require patients to adhere to a pre-determined schedule where activity and  rest are planned and consistent[19,20]. Should a person begin to feel worse, most regimes permit a temporary reduction in the duration, intensity and/or speed of activities but the general advice is to expect some setbacks and not to rest or stop [18-20].

History

Pacing was initially devised during the 1980s for patients with ME as it was known in the UK, and epidemic neuromyasthenia (EN) as it was referred to in the USA [12, 21-24]. ME/EN often occurred in clusters and the nature of the symptoms as well as the mode of transmission led many to assume an infectious aetiology [21,24]. However, as patients were rarely followed-up after the outbreaks, ME was considered to be an acute condition and there is little evidence that management extended beyond symptomatic treatment and the advice to rest [23,24]. This changed when the tendency for ME to become chronic was recognised in 1978 [24]. Having observed the “threshold of physical activity which, if exceeded, is followed by a relapse and recurrence of acute symptoms” [25], Dr Melvin Ramsay advocated that “each patient must determine that threshold and adopt an appropriate pattern of living”.   
The latter became the basis for more detailed guidelines. The term ‘pacing’ was chosen by one of the authors (EMG) since the advice for patients with ME/EN [26] resembled that found in books on coping with other chronic conditions. Although most of these did not use the word ‘pacing’ and definitions varied, one writer [27] described it as “identifying which activities one is able to do, how often, under what circumstances... pacing is not a static decision but necessarily fluctuates with the monitoring of  the physiological imperative... rest is prescribed… for symptom control”.  As advisor to support groups, Goudsmit promoted pacing in factsheets and other publications [26] and subsequently assessed a programme which included pacing in a controlled trial [16,21]. 
Criticisms concerning the potential dangers of rest and further deconditioning [19,20,28,29] were considered, but it was felt that the symptom-contingent approach was safer and more appropriate for a number of reasons. Firstly, the time-contingent activity strategies were generally based on rehabilitation programmes designed for chronic pain [30,31]. These programmes challenge the therapeutic benefits of rest after the acute phase where symptoms are no longer regarded as a sign to avoid further tissue damage, and assume that any residual pain and ‘flare-ups’ can be managed satisfactorily using other interventions such as opiates, physical therapy, stress management and cognitive-behaviour therapy (CBT) [32]. Some of these programmes follow operant conditioning principles, so responses such as sympathy from significant others are considered as positive reinforcers of the illness behaviour. Moreover, given that inactivity is associated with an increase in deconditioning, muscle wasting, osteoporosis and depression, it has been argued that symptom-contingent rest might exacerbate and perpetuate the disability [32]. Time-contingent approaches for chronic pain [32] were therefore devised to cut down on “excessive” rest and to break the association between symptoms and a reduction in activity. Although the protocols were adapted for ME/CFS, many share elements from the operant conditioning paradigm and cite support from the literature on chronic pain [19,20,33].  
While recognising the potential benefits of such programmes for subsets of patients (see below), several researchers and practitioners felt that the growing evidence of ongoing pathology supported the view that internal cues might well signal the need for protective action [23,34-50]. Accordingly, pacing encourages the person with ME/CFS to recognise discomfort and to not ‘push’ themselves, in order to prevent an exacerbation of symptoms. Another difference between chronic pain and ME/CFS, which was considered when evaluating the benefits of pacing, was the fact that ME/CFS is not the result of a localised or stable lesion, and as a contested illness, patients are less likely to experience social reinforcement such as sympathy or financial gain [20,21,23,55]. In relation to the postulated consequences of inactivity, there have been no reports, to our knowledge, of muscle wasting or other signs of disuse in ME/CFS and research has failed to show a significant correlation between deconditioning and symptomatology [51]. Graded activity protocols may not be indicated for the patients with ME/CFS who have remained ambulant and consistently function at their activity ceiling [31]. Also taken into account were the findings from objective measures demonstrating that the graded exercise protocols do not result in significant increases in activity, and that the documented improvements in fatigue and physical functioning cannot be ascribed to changes in physical fitness [52-54]. Other considerations include the lack of information on the efficacy of time-contingent protocols in people with evidence of  neurological or immunological disease [23,34-50]. 
	Having examined the available therapeutic options, American researchers also showed a preference for a symptom-contingent strategy. Jason’s Energy Envelope Theory is based on the hypothesis that the avoidance of exertion-related setbacks and relapses increases energy levels and the tolerance of activity [13]. Thus patients who tend to over-exert themselves are advised to cut back while those who are inactive for long periods are encouraged to gradually increase their activity. The articles on the Envelope Theory are significant as they brought pacing into the scientific domain and encouraged further research, not only into the benefits and limitations of the strategy, but also into the possible mechanisms underlying PEM [56-60].  

Pacing in practice: current guidelines and evidence 

It should be acknowledged that the application of pacing requires a large behavioural change for the patient with CFS; hence clinicians are advised to spend sufficient time explaining the rationale for this strategy prior to initiating the programme. Instruction is preferentially done in an individual client-therapist session, but we recommend that patients also be given literature summarising the instructions and noting the positive feedback from surveys [61-62]. If the individual understands why the strategy is appropriate and that many before them found it very helpful, the likelihood of compliance will increase. 

Symptom-contingent pacing  

To maintain an optimal level of activity over time, it is important that patients with ME/CFS have an accurate view of their capabilities and the required discipline to stop in response to internal cues of PEM. Some individuals find it relatively easy to assess their health status, whereas others may benefit from keeping a diary. This can be as simple as rating fatigue every day on a 100 point scale where 0 means ‘no fatigue’ and 100 means ‘extreme fatigue’. Perceived energy can be given a score from 0 representing ‘no energy at all’ to 100 denoting ‘energy similar to that when well’. A third score should assess expended (used) energy, where 0 means ‘no energy expended’ and 100 means ‘all energy used up’ [56-60]. Following the advice to try and match perceived and expended energy according to the Envelope Theory, the therapist and patient can review the data after two weeks to ascertain whether the patient was able to establish a comfortable range of energy expenditure as reflected in the scores for fatigue. If there is a discrepancy between perceived and expended energy, the patient may be asked to rate themselves every hour or two hours for a few days, to identify the time of the over- or under-exertion and enable a review of their activities to reduce the fluctuations.
 Alternatively, some patients prefer to follow the protocol devised by Ho-Yen [63]. Based on the view that “recovery depends on knowledge”, patients are instructed to rate themselves on a scale from 0 (worse) to 10 (best) on one side of the diary and note the hours they slept and spent relaxing, their main activities, any source of stress, and their overall view of the day on the other side. If this does not give an insight into a person’s limitations and triggers of  PEM, Goudsmit and Howes [12] also suggest that patients record what they ate and drank for a few days, plus the time of the onset or worsening of symptoms, given that sensitivities to foods are relatively common in ME/CFS. As most relapses do not occur at random, a diary will not only help to identify relevant triggers but also enable both the patient and practitioner to monitor the effects of pacing and other coping strategies. 
Depending on the severity of the symptoms and the type of activity which triggered it, the patient may choose to respond either by resting, or if the fatigue is localised, by switching to an activity which uses a different muscle group. The advice to pace and switch is based on the observation that ME tends to affect some muscles more than others [23] and the hypothesis that switching before or at the first sign of  PEM may abort the mechanisms underlying activity-induced increases in symptoms [12,26,35-44].  It is therefore proposed that switching extends the available energy to a greater degree than the less complicated version of pacing described above.
In practice, pacing and switching requires patients to stop an activity when it is convenient and before or at the first sign of PEM. They can subsequently switch to an activity that involves a different muscle group, e.g. after walking or cycling, they can sit down and spend some time reading or meditating.  This approach may be a useful additional option for patients who have already established their tolerance thresholds and appreciate the freedom of being able to choose activities according to their circumstances and preferences. However, following the principle of pacing, they stay within their ‘envelope’ and respond to warning signs when they become aware of them. Early feedback supports the view that switching helps some individuals to optimise their energy levels; however, others have reported that the additional monitoring is overly intrusive and that the frequent changing of activities makes little difference.
It should be emphasized that pacing is not only appropriate for activities involving physical exertion. Sedentary activities such as reading, talking on the telephone and using the computer can also result in setbacks. However, as visual disturbances such as intolerance to light, dry eyes and halos are unlikely to be due to exertion-related muscle weakness [64-65], such symptoms should be investigated and managed by a qualified professional. 
It is also important to recognise that activities which demand concentration and memory can induce and exacerbate symptoms [16,19]. Patients should be made aware that even an innocuous telephone call may result in adverse reactions, possibly due to an impairment in information processing [66]. Moreover, they should be warned that the onset of cognitive symptoms is often delayed and that they cannot depend on the usual signs that they have reached their limits. For this reason, we recommend the use of external cues such as a kitchen timer to pace activities involving concentration. If the individual has little idea of their tolerance levels for cognitive tasks, they should try and establish a baseline that does not result in PEM, for example, by starting with 10 minutes twice a day, and slowly increasing the duration.   
We have seen no evidence that it is advantageous to divide up minor tasks.  However, it may be helpful to restrict the number of demanding or stressful activities to one a day and in severely affected patients; two a week. It has been suggested that stress adds to the illness burden by activating the hypothalamic-pituitary-adrenal (HPA) axis, which in turn can result in lower cortisol levels and impair the immune system [17,39,43,57]. This mechanism may also explain the prolonged recovery after challenging events [11,15]. Although a stressful activity may not precipitate an exacerbation of symptoms on the same day, it is advisable to spend the remaining hours doing less exhausting but meaningful tasks interspersed with periods of rest and relaxation [60]. Moreover, if tolerance levels have not been determined, this schedule should be maintained for 48 hours as the majority of adverse reactions begin within this time frame [15,39].   
Once a person has a basic idea of what they are able to tolerate, they can make provisional plans for the days or weeks ahead, as long as they respond swiftly to the onset or increase in symptoms. However, as ME/CFS is also influenced by variables such as concurrent infections, the menstrual cycle and the weather, patients are not encouraged to set goals and targets for the days ahead [12,57]. A flexible approach which allows them to adjust their activities without feeling that in doing so, they have failed themselves or their doctor is preferable. Indeed, the only goals should be to avoid exertion-related setbacks and to find the most effective coping strategies to deal with other physical, emotional or environmental factors that impact on their health. 
When symptoms improve, patients experience less weakness and fatigue during the day so following the principles of pacing, their tolerance for activities should increase. Regular reviews to ascertain how energy is used in daily life can assist in reprioritising tasks and optimise daily functioning [57,67]  If increases in activity do not result in symptom flare-ups for three months and patients feel that they are close to about 60 to 70% of their former functioning, they may wish to change to a gentle form of graded exercise therapy (GET), starting at a low level and increasing incrementally in duration and intensity to further increase their fitness and tolerance thresholds [18].  
One symptom-contingent graded exercise programme has been evaluated in a randomized controlled trial (RCT) [68]. Increases in exercise were advised only when patients felt that they were coping with their current activity levels as determined by average scores on a perception of effort scale. Moreover, patients were allowed to stop if they experienced a relapse or if symptoms became worse. The 12 week programme improved resting systolic blood pressure, work capacity, depression, mental fatigue, perceived exertion, net blood lactate production and performance on a cognitive test. In addition, 91% of the participants rated themselves as ‘better’ in respect to their overall health, while no one felt that the exercise/pacing programme made them worse.  Perceived fatigue scores fell by 30% in the exercise group compared to 15% in the relaxation/flexibility controls. This trial of pacing is particularly noteworthy because it did not include additional interventions such as relaxation exercises, counselling or CBT. It therefore provides support for the basic principle of remaining as active as possible within the limits imposed by the illness. However, the modest reduction in fatigue, the lack of a follow-up and the failure to use an objective measure of activity to confirm compliance means that the findings should be interpreted with caution.  
There have been no other controlled trials of symptom-contingent pacing but the strategy has been included in a number of multi-component programmes which have shown promising results [16,70-72]. For example, a study evaluating a physician-led programme conducted in a hospital practice revealed significant differences between the treated patients and controls for fatigue, somatic symptoms and self-efficacy at six months [16]. Moreover, 23% of the patients had improved to such a degree that they were discharged back to their general practitioner. These improvements were maintained at the 12 month follow-up and the attrition rate was extremely low. However, the lack of an objective measure to assess activity levels means that it is not possible to confirm compliance or examine the relationships between rest, activity and outcome. Moreover, some patients who felt relatively well reported feelings of boredom, isolation and depression during the periods of pre-emptive rest, i.e. the time engaged in relaxation and inactivity which are not a response to symptoms but form part of  the day’s schedule to stay within the ‘envelope’. As a result, patients are now advised to limit these periods to 30 minutes, two to four times a day and to follow each with an enjoyable activity. This approach not only counteracts boredom but can also act as positive reinforcement. Overall, the findings of the study above and those of other controlled trials support the view that pragmatic and flexible, multi-dimensional programmes incorporating pacing are acceptable and helpful in the management of ME/CFS. However, the duration of pre-emptive rest should be limited to prevent rumination and excessive focusing on symptoms as these may have adverse effects on outcome [16,73].  
While there is a paucity of RCTs, two studies provide additional evidence of the value of symptom-contingent pacing. For example, a RCT comparing four different non-pharmacological interventions included measures of perceived energy and expended energy [58]. None of the interventions - CBT, coping skills, relaxation and anaerobic activity - explicitly focused on energy management and the Envelope Theory. The data from all interventions obtained at follow-up were pooled and participants were classified as either having stayed within or having gone beyond their energy envelope. It was found that the former reported significant improvements in physical functioning and fatigue severity over time compared to those who had not paced themselves, irrespective of treatment.
A second analysis [59] using the results from the same study showed that the individuals who functioned within their energy envelope before starting treatment demonstrated significantly greater improvement in fatigue severity (16%) and physical functioning (37.6%) compared to those operating outside their energy envelope at baseline (2.7% and 6% improvement respectively).  Thus without specific advice on energy management, those who were already pacing themselves continued to do so and had better outcomes than those who did not pace themselves before or during the programme. In addition, the data obtained from actigraphy  revealed that those who had paced themselves and increased activity reported significantly greater improvements in fatigue at the 12 months follow-up compared to those who had paced themselves but had not increased their activity levels. These findings are congruent with the theory that individuals who expend only as much energy as they have available achieve a better outcome, and thus challenges the suggestion that symptom-contingent pacing is a form of maladaptive avoidance behaviour that will leave the patient “trapped… in the envelope of ill health” [75]. Conversely, the findings indicated that those who overextended themselves and increased activity did not improve, supporting the need to differentiate between high functioning or ‘active’ patients and low functioning or ‘passive’ patients [31]. 

Programmes combining time and symptom-contingent pacing. 

One of the new self-management programmes being evaluated uses the principle of pacing, but incorporates an initial phase aimed at building confidence as well as reducing the fluctuations in symptoms [69]. During the first session, the patients are asked to estimate their physical capabilities before commencing a normal daily activity such as shopping or housework in order to establish a baseline. If the therapist suspects that an individual has overestimated their abilities, he or she recommends that the patients reduce their activities, taking into account their perception of the severity of their illness that day. For example, if people believe that they are capable of walking for 20 minutes without exacerbating  their symptoms, the therapist will advise them to walk for no longer than 15 minutes (25% below their baseline), followed by a 15 minute break. The patients are then asked to review their condition and if symptoms have not increased, they are permitted to walk for a further 15 minutes. However, on ‘bad days’, patients are advised to reduce the duration of the walk to 10 minutes (i.e. 50% of baseline). Each agreed activity block is always interspersed with breaks, with the length of this break equating to the duration of the activity. ‘Breaks’ are defined as periods when the person relaxes or engages in light activity (e.g. reading) and are aimed at preventing a setback. This phase differs from the original principle of pacing in that the first stage tends to advocate a level of functioning below the person’s perceived abilities. However, the duration of the activities is influenced by the symptoms and the protocol includes the element known as switching.  
When patients are able to manage their daily activities and symptom fluctuations are reduced to a manageable level, the therapist starts the grading phase aimed at increasing activity levels. The regime is gentle, flexible and as before, tailored according to each individual’s capabilities. Thus on a good day, patients are advised to increase the duration of an activity by a number of minutes above the time established at baseline. Importantly, they are instructed not to exercise above this level until they are able to cope with the current schedule. Moreover, on days when they feel worse, they are allowed to reduce or stop the session.  
The use of a motion-sensing device such as a pedometer is recommended as it provides more reliable information on the duration of the activities undertaken. Likewise, a small notebook to record data on symptoms, mood and overall daily functioning reduces the errors associated with memory recall and helps to identify relationships between activities  and both physical and emotional health. Both aids may also be valuable in monitoring the effect of any behavioural changes and having a visible record of improvement is likely to increase the patient’s sense of control.
The results from uncontrolled trials evaluating this programme have been promising and a recent RCT found a clear treatment effect of pacing over relaxation for self-reported health status assessed using the SF-36 (Nijs, personal communication). Based on the information accrued to date, we believe that this protocol may be particularly suitable for patients who have encountered difficulties in establishing their tolerance levels on their own or who prefer a more structured programme [67]. It also offers a strategy for severely affected individuals who don’t report ‘good’ days.  A study comparing symptom-contingent pacing and the combination programme may help to clarify if one approach is superior to the other and whether one is more effective for specific subsets.    
The most recent intervention to be evaluated, adaptive pacing therapy (APT), evolved from advice offered by a patient group and is aimed at “achieving a level of activity that can be managed on a regular basis without experiencing an increase in symptoms” [76]. As well as instructions on planning activity and rest, the protocol also provides patients with information on relaxation techniques, improving sleep, posture, ergonomics and dealing with pressure from friends and relatives. Of note is that individuals are encouraged to listen to their body and to prioritize and alternate (switch) activities. However, the rationale behind the 70% rule, defined as ”never going beyond 70% of a person’s perceived energy limit”, is unclear.   
Interestingly, a recent study which compared APT with CBT, GET and specialist medical care [77] found that APT had little effect. Reductions in fatigue, physical functioning were minimal and there were fewer reports of PEM after CBT and GET. Significantly, 63% of the people in the APT group still reported PEM at follow-up which raises the question of compliance. Without the data from actigraphy, it is not possible to assess whether some of the participants may have operated at much lower levels than advocated. Any additional periods of pre-emptive rest could have provided patients with more time to focus on symptoms and the intrusiveness of the illness on daily life. This is regarded as a maladaptive coping strategy associated with poor outcome [16,73]. The results from this trial are therefore consistent with the advice that pre-emptive rest should only be used to establish tolerance threshold and enable the individual to stay within their ‘envelope’. However, given the nature of ME/CFS, these periods may be increased during relapses, when a strategy such as that described in the combination programme might be helpful in returning the patient to a level of functioning where exacerbations are minimal or avoided. The findings in relation to APT also challenge the notion that doing less than one can promotes healing [75].

Indications 

Based on experience and the available evidence, we recommend pacing as a first-line strategy to manage activity levels for individuals who report marked fluctuations in symptoms [13,19,22,23] and/or where there is sound evidence of an underlying disease process that may be aggravated by a time-contingent exercise programme [34,36,38,40,50,77-82]. Of particular concern are the unknown effects of the abnormal neurological [37,45,46,48], immunological [39,41,42-44] and metabolic [35,49] responses to exertion documented in the literature. These indicate that internal cues may well signal a potential for harm [75]. At the time of writing, there is little support for the view that the abnormalities are the result of  phobic avoidance [11,83,84] or deconditioning [51], thus if the person is ambulant and shows no signs of muscle wasting, practitioners may wish to start a management programme using a symptom-contingent protocol.     
Pacing is also appropriate for the many patients with ME/CFS who have tried a graded activity programme but were not able to increase their activity levels due to  PEM. The inability to increase activity levels beyond the individual’s ‘ceiling’ was documented in a recent study assessing a graded exercise programme [52].  Using an accelerometer to measure daily activity, Black and McCully observed that the increases during the trial were restricted to the first 4-10 days, after which both walking and total activity counts decreased. Although it could be argued that the targets may have been too ambitious, the results are consistent with the findings from other programmes aimed at increasing activity levels. Whereas subjective reports often suggest an improvement [18], studies utilizing objective measures have shown that increases were either non-significant or transient [53,54,85].  
A major advantage of  symptom-contingent pacing compared to the combination  programme is that the former can be explained by a physician or practice nurse during a routine consultation immediately following diagnosis. A review after about two weeks is recommended in order to identify the patients who have problems in establishing their limits or have difficulties accepting the adjustments to their lifestyle. After a month, a follow-up should reveal that the condition has begun to stabilise, and that the person is functioning at a level they can tolerate. Surveys conducted amongst patient groups have consistently shown that this basic strategy is regarded as both acceptable and helpful [12,61,62]. However, if an individual reports difficulties, this alone is a reason to refer the person for more specialist care. 

Limitations 

One of the most common problems reported in relation to pacing is the reluctance to stop an activity before it has been completed. This is perhaps the main reason why, at least in the initial phase of the illness, many individuals continue to operate well beyond their limits, resulting in a bursts of activity followed by setbacks [19,20]. There are also individuals who push themselves because they do not understand the significance of the relationship between their symptoms and exertion, or because they prefer to adopt a fighting attitude [12]. Others have admitted that they lack the self-discipline required for the symptom-contingent approach and might therefore benefit from a more structured programme and additional input from a health care professional [12]. 
Similarly, pacing may not be appropriate for those who are bedbound and require specialist help, or where people are avoiding even minimal activity due to fear of exacerbating symptoms, perpetuated by a misunderstanding of advice from doctors, support groups or the internet [20,28]. Moreover, if the main symptoms such as fatigue are not closely linked to exertion, or if patients are well on the way to recovery, then a rehabilitation programme which includes a time-contingent  exercise component may be more effective [18].
It has been argued that close monitoring of bodily changes intensifies the perception and experience of symptoms [20]. Although this may only be applicable to a small number of cases, there is evidence that focusing on symptoms is associated with increased impairment, anxiety and depression [73] as well as poor outcomes [86,87]. However, pacing requires that individuals respond to symptoms as they become aware of them, so constant monitoring is unnecessary and a waste of limited energy. Interestingly, the literature also describes the reverse phenomenon. The existence of the boom-bust pattern of activity [19,88] implies that some individuals pay too little attention to internal cues. Depending on the person’s preferences and circumstances, both the strategy based on the Envelope Theory and the combination protocol may help to reduce exertion-induced fluctuations and thus increase the patient’s sense of control [20].   
Finally, some lay articles have described pacing as a therapy or treatment. This suggests that it can reduce a broad range of symptoms and possibly lead to recovery. It should be noted that advocates of the strategy outlined above have made no claims that it can alleviate visual disturbances, thermoregulatory abnormalities, dizziness and some of the other symptoms associated with ME/CFS. Furthermore, there is no reason why pacing cannot be combined with cognitive-behavioural interventions to address aspects of the illness that may be influenced by maladaptive beliefs [20,87-89]. Indeed, given the disability associated with ME/CFS, one would expect that a programme which also provides information, emotional support and advice on nutrition, sleep and dealing with stress, to be superior to pacing or any other treatment modality offered on its own [90]. This hypothesis requires further evaluation, but until there is more clarity, we advocate an approach to exercise which acknowledges the complexity of ME/CFS and does not add to the disability and distress caused by PEM. 

Conclusion

Pacing is recommended by many national support groups as well as an increasing number of health professionals as a strategy to reduce the exertion-related symptoms of ME/CFS. However, the absence of a standardised definition has resulted in different protocols, creating confusion and complicating the evaluation of research. Our specialist interest in the illness led us to devise a working definition to differentiate pacing from related approaches and develop guidelines for use in clinical practice. 
Based on the information available, we submit that pacing is a flexible, pragmatic, acceptable and helpful coping strategy which may be used in the self-management of ME/CFS or as part of a tailor-made, multi-component programme. We hope that this review provides a scientific foundation for further dialogue with practitioners, researchers and others interested in increasing their knowledge of pacing and improving patient care.     
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